Event Attendee

Hunter Diamond

- ProPhase Labs, Inc. entered into an **At-the-Market Sales Agreement** with WestPark Capital, Inc. on **October 9, 2025**.  **[868278_0001493152-25-018123_form8-k.htm:1]** 
- This agreement allows the company to **offer and sell shares of its common stock** through WestPark Capital, Inc. as its sales agent.  **[868278_0001493152-25-018123_form8-k.htm:1]** 
- WestPark Capital, Inc. will receive **3.0% of the gross proceeds** from the sales of any shares as compensation.  **[868278_0001493152-25-018123_form8-k.htm:1]** **[868278_0001493152-25-018123_ex1-1.htm:36]** 
- The sales will be made under the company's Registration Statement on Form S-3, which was declared effective by the SEC on **November 20, 2024**.  **[868278_0001493152-25-018123_form8-k.htm:1]**

ProPhase Labs (PRPH)